A pathway in quiescent cells that controls p27Kip1 stability, subcellular localization, and tumor suppression

被引:176
作者
Besson, A
Gurian-West, M
Chen, XY
Kelly-Spratt, KS
Kemp, CJ
Roberts, JM [1 ]
机构
[1] Howard Hughes Med Inst, Div Basic Sci, Seattle, WA 98109 USA
[2] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA
关键词
p27(Kip1); cyclin; CDK; tumor suppressor; tumorigenesis; Ras; lung cancer;
D O I
10.1101/gad.1384406
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
We have created two knock-in mouse models to study the mechanisms that regulate p27 in normal cells and cause misregulation of p27 in tumors: p27(S10A), in which Ser10 is mutated to Ala; and p27(CK), in which point mutations abrogate the ability of p27 to bind cyclins and CDKs. These two mutant alleles identify steps in a pathway that controls the proteasomal degradation of p27 uniquely in quiescent cells: Dephosphorylation off p27 on Ser10 inhibits p27 nuclear export and promotes its assembly into cyclin-CDK complexes, which is, in turn, necessary for p27 turnover. We further show that Ras-dependent lung tumorigenesis is associated with increased phosphorylation on Ser10 and cytoplasmic mislocalization of p27. Indeed, we find that p27(S10A) is refractory to Ras-induced cytoplasmic translocation and that p27(S10A) mice are tumor resistant. Thus, phosphorylation of p27 on Ser10 is an important event in the regulation of the tumor suppressor function of p27.
引用
收藏
页码:47 / 64
页数:18
相关论文
共 53 条
  • [1] Etheno-adduct-forming chemicals: from mutagenicity testing to tumor mutation spectra
    Barbin, A
    [J]. MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH, 2000, 462 (2-3) : 55 - 69
  • [2] p27Kip1 modulates cell migration through the regulation of RhoA activation
    Besson, A
    Gurian-West, M
    Schmidt, A
    Hall, A
    Roberts, JM
    [J]. GENES & DEVELOPMENT, 2004, 18 (08) : 862 - 876
  • [3] Involvement of p21Waf1/Cip1 in protein kinase C alpha-induced cell cycle progression
    Besson, A
    Yong, VW
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2000, 20 (13) : 4580 - 4590
  • [4] Regulation of the cytoskeleton: An oncogenic function for CDK inhibitors?
    Besson, A
    Assoian, RK
    Roberts, JM
    [J]. NATURE REVIEWS CANCER, 2004, 4 (12) : 948 - 955
  • [5] A growth factor-dependent nuclear kinase phosphorylates p27Kip1 and regulates cell cycle progression
    Boehm, M
    Yoshimoto, T
    Crook, MF
    Nallamshetty, S
    True, A
    Nabel, GJ
    Nabel, EG
    [J]. EMBO JOURNAL, 2002, 21 (13) : 3390 - 3401
  • [6] SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
    Carrano, AC
    Eytan, E
    Hershko, A
    Pagano, M
    [J]. NATURE CELL BIOLOGY, 1999, 1 (04) : 193 - 199
  • [7] Requirement of p27(Kip1) for restriction point control of the fibroblast cell cycle
    Coats, S
    Flanagan, WM
    Nourse, J
    Roberts, JM
    [J]. SCIENCE, 1996, 272 (5263) : 877 - 880
  • [8] CRM1/Ran-mediated nuclear export of p27Kip1 involves a nuclear export signal and links p27 export and proteolysis
    Connor, MK
    Kotchetkov, R
    Cariou, S
    Resch, A
    Lupetti, R
    Beniston, RG
    Melchior, F
    Hengst, L
    Slingerland, JM
    [J]. MOLECULAR BIOLOGY OF THE CELL, 2003, 14 (01) : 201 - 213
  • [9] The cyclin-dependent kinase inhibitor p27Kip1 is stabilized in G0 by Mirk/dyrk1B kinase
    Deng, XB
    Mercer, SE
    Shah, S
    Ewton, DZ
    Friedman, E
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (21) : 22498 - 22504
  • [10] A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice
    Fero, ML
    Rivkin, M
    Tasch, M
    Porter, P
    Carow, CE
    Firpo, E
    Polyak, K
    Tsai, LH
    Broudy, V
    Perlmutter, RM
    Kaushansky, K
    Roberts, JM
    [J]. CELL, 1996, 85 (05) : 733 - 744